Live feed07:30:00·2dPRReleasevia QuantisnowNeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026ByQuantisnow·Wall Street's wire, on your screen.NPCE· Neuropace Inc.Health Care
